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Objective  
To examine patients’ beliefs about their Familial Adenomatous Polyposis (FAP), and their socio-
demographic, genetic and clinical characteristic in relation to adherence to endoscopic surveillance 
and health-related quality of life (HRQoL).  
Methods  
Adult patients on the national Swedish polyposis registry diagnosed with FAP who had 
undergone prophylactic colorectal surgery (N=209, 76%) and agreed to participate completed 
the Illness Perceptions Questionnaire and SF-36 HRQoL.  
Results 
Non-adherence (14%) to surveillance was associated with being older, having less recently 
undergone surgery and no previous history of malignancy. Patients’ beliefs about their FAP were 
able to explain unique variance in non-adherence, in particular those who believed FAP was less 
distressing and serious (Χ
2
=48.48, P=0.01, R
2
=0.381). Men were more likely to view FAP as less 
distressing (r= -.215
, 
p<0.01) and serious (r= -.231
, 
p<0.01). Those with family members with 
FAP, and more positive perceptions of FAP, viewed FAP as less serious (r = -.218, p<0.01) 
compared to those without experience of family members with FAP. HRQoL was no worse in 
those who had attended surveillance, but poorer physical HRQoL was associated with older age, 
testing positive for genetic mutations, and more negative illness perceptions, in particular, a 
greater illness identity, serious FAP consequences and poorer treatment control (R
2
=0.319, 
F=6.723, p<0.001). Mental HRQoL was worse in younger patients, without experience of a 
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family member with FAP, and more negative, or unrealistic perceptions of FAP (R
2
=.319, 
F=6.723, p<.001).  
Conclusions  
Despite the greater risk of future malignancies, increased complacency was associated with 
more positive views about FAP. 


	Illness perceptions, FAP (Familial Adenomatous Polyposis), genetic:risk, 
surveillance, adherence, cancer:registry  
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 !	

Patients with the hereditary colorectal cancer syndrome Familial adenomatous polyposis (FAP) [1] 
are confronted with several symptoms associated with constraints in physical and mental health [2, 
3]. FAP requires prophylactic removal of the colon, followed by life:long endoscopic surveillance. 
The removal of the colon (ileorectal anastomosis [IRA]) or the colon and rectum (ileal pouch:anal 
anastomosis [IPAA] or ileostomy) is recommended for patients between the ages of 18 and 20 years 
[4, 5]. Without prophylactic surgery and life:long endoscopic surveillance, FAP is associated with a 
100% risk of developing colorectal cancer [1]. Consequently, prophylactic colorectal surgery and 
continued adherence to endoscopic surveillance are vital for survival [2, 6]. Non:adherence to 
endoscopic surveillance in those with FAP has been reported to range anywhere from 14%
 
[7] to 
46% [6]. Traditionally, care for patients with FAP has focused on cancer prevention i.e. endoscopic 
examination with removal any polyps [4]. Recent research taking patient’s experiences into account 
has shown that living with FAP includes a sense of a constant threat to health [3] and that the 
disease influences people’s quality of life in several ways, independent of age and time since 
diagnosis [2, 3, 8].  Specific concerns that have been pointed out by patients are changed food and 
toilet habits and burdensome abdominal symptoms that occur irr gularly [3, 8] as well as the burden 
of commitment to lifelong endoscopic surveillance [3]. However, there are still individual 
differences in patient’s quality of life and unexplained variance in adherence that surgical 
procedures and symptoms alone cannot fully explain. 
 
Meyer et al.’s [9] model of self:regulation of illness representation provides an explanation for the 
variation in how an illness may be perceived and responded to by the patient [10]. The model 
organises illness representation around the following dimensions: identity (symptoms associated 
with the illness), timeline (beliefs about the duration of the illness), cyclical timeline (beliefs about 
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the cyclical nature of the symptoms), consequences (beliefs about the negative impact of the illness 
on life), control (beliefs about the controllability of the illness), treatment control (beliefs about the 
effectiveness of treatment), illness coherence (a coherent understanding of the illness), the emotional 
representations (the extent to which the illness is emotional) and cause (perceived causes of the 
illness). The model posits how a patient’s emotions and cognitions are related to perceived health 
threats, such as symptoms [9, 11, 12], and guides actions (e.g., adherence or non:adherence to 
treatment) to minimise these perceived threats [13, 14]. It is well documented that a negative illness 
perception, such as less understanding of an illness, viewing the illness as serious, and attributing 
negative consequences to the illness, is related to distress and poorer HRQoL in patients with a wide 
range of illnesses [10, 15:18]. 
 
There is increasing evidence of the utility of the self:regulation model in the context of pre:
cancerous and increased genetic familial risk of malignancy [16:19].  Women with increased genetic 
risk of ovarian cancer who have reported more negative illness perceptions of ovarian cancer risk 
were also found to be at greater risk of suffering with ovarian cancer:specific disease [17] and 
women with greater familial risk of breast cancer perceived cancer as more serious, worried more 
and exhibited more maladaptive copying strategies [16]. Illness perceptions and in particular beliefs 
that treatment is effective, have also proved useful in discriminating women with abnormal cervical 
screening tests who do not complete recommended treatment (10% of their sample) compared to 
those that did complete treatment [19]. Moreover, the self:regulation model has proved a useful 
framework to develop interventions to improve patient outcomes following a brief cognitive 
intervention [20, 21].  
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This study set out to examine patients’ beliefs about their FAP and to investigate the extent to which 
these beliefs are associated with their adherence to surveillance and quality of life, over and above 
their socio:demographic background, genetic and clinical characteristics.  
 
"

Sample and Design 
The study employed a cross:sectional design. All patients in the national Swedish polyposis registry 
diagnosed with FAP who had undergone prophylactic colorectal surgery and were aged 18–75 years 
(=276) were considered eligible and invited to participate; one patient did not speak Swedish and 
was therefore excluded. Of the remaining 275 patients, 209 (76%) consented to participate.  
Instruments 
Illness perception was assessed with the Revised Illness Perception Questionnaire (IPQ:R)[22]. The 
questionnaire includes nine components: 	
	 (6 items; e.g., “My condition is likely to 
be permanent rather than temporary”); 			 (4 items; e.g., “My symptoms come and go 
in cycles”);	 (6 items; e.g., “My condition has major consequences on my life”); 
	 (6 items; e.g., “There is a lot which I can do to control my symptoms”); 
	(5 items; e.g., “My treatment is effective in curing my illness”);  (6 
items; e.g., “Having this illness makes me feel anxious”); 	
	 (5 items; e.g., “I have a 
clear picture or understanding of my condition”);  (18 items; e.g., hereditary, chance or bad 
luck, overwork), and identity (17 symptoms; e.g., stomach pain, weight loss, fatigue). The 
respondents are asked to indicate their level of agreement with the posed statements on a 5:point 
Likert scale ranging from 1 (“strongly disagree”) to 5 (“strongly agree”). Higher scores on the 
timeline:chronic and timeline:cyclical components represent endorsing beliefs that the condition is 
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lasting or cyclical rather than acute or stable in nature. Higher scores on the consequences and 
emotional representation components represent endorsing beliefs that the condition will have a 
negative impact on life and more negative emotional responses to the illness, whereas higher scores 
on the personal control, treatment control, and illness coherence components represent a positive 
belief about personal control, the effectiveness of treatment and a greater perceived understanding of 
the illness. Finally, the identitycomponent is measured by 17 stated symptoms that the patients 
endorse as being induced by the disease. On the recommendation of the developers of the IPQ:R, the 
illness identity component should include illness:specific symptoms, in addition to more general 
symptoms (e.g., fatigue and sleeping difficulties). Higher scores on the identity component reflect a 
higher number of symptoms attributed to the illness. The Swedish version of the IPQ:R has shown 
good internal consistency and test:retest reliability [23]. In the present study, Cronbach’s α 
coefficients for the IPQ:R components were all above 0.70, except treatment control α= 0.622, 
although all item:total correlations were above 0.3. In addition, the item ‘My disease is very 
unpredictable’ was dropped from cyclical timeline in order to achieve an α > 0.7, as it did not seem 
to correlate with other items on the cyclical timeline sub:scale.   
 
The SF:36 was used to measure HRQoL [24, 25]. The physical component summary score and 
mental component summary scores summaries: physical functioning, role physical (role limitations 
due to physical health), bodily pain, general health, vitality, social functioning, role emotional (role 
limitations due to mental/emotional health), and mental health [24].  Greater weights are applied to 
physical functioning, role functioning, bodily pain and general health for the physical component 
summary score and the remaining domains to the mental component summary score. Higher scores 
represent better HRQoL.   
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Procedure  
A letter was sent to those patients in the Swedish Polyposis Registry who fulfilled the inclusion 
criteria. The letter included information about the study and contained a package of questionnaires. 
The letter emphasised that participation was voluntary and that nonparticipation or withdrawal of 
consent would not affect a patient’s care or treatment. The patients who subsequently agreed to 
participate were asked to complete the set of questionnaires and to return them in an enclosed 
prepaid envelope. Patients who did not return the questionnaires were sent a reminder after three 
weeks. All the returned questionnaires were checked for missing data, and the participants were 
contacted by phone for completion when necessary. Ethical approval was granted by the Regional 
Ethical Review Board in Stockholm. 
 
Demographic (e.g. age and gender) and additional clinical characteristics (diagnosis, age at 
diagnosis, time since surgery, age at surgery, type of surgery, FAP in the family, and adherence to 
endoscopic surveillance) were obtained from the Swedish Polyposis Registry. Patients were 
considered non:adherent if they had not undergone endoscopic examinations (lower or upper 
gastrointestinal tract) within one year after recommended intervals. Participants with a family 
history of FAP (having FAP within the family) were registered as “FAP in the family”. 
 
Data analysis 
Statistical analyses were performed with the Statistical Package for Social Sciences (SPSS) for 
Windows version 22.0 (SPSS Inc. Chicago, IL, USA). Descriptive statistics were computed for 
scales and standardised questions. Pearson’s Correlations were used for continuous level measures 
and point:biseral correlations were used for nominal level data.  Hierarchical logistic and linear 
regression analyses were computed to regress socio:demographic and clinical factors, and the 
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components of the IPQ:R onto adherence and quality of life:  (i) socio:demographic factors such as 
age, sex and educational attainment (ii) FAP in the family and genetic status (iii) the time since 
diagnosis and the time since last colorectal surgery and (iv) illness perceptions were force entered 
into the model in sequential steps. Assumption testing was through examining:  (i) standardised 
residuals (required to be <3.00), (ii) leverage (<1.00), (iii) Cook’s distance (<1.00), and (iv) variable 
inflation factors (co:linearity <10).  The models were evaluated by a significance level of p<0.05), 
R
2
 and in the logistic regression, the percentage of cases correctly classified. 
 
#
The demographic and clinical characteristicsof the sample are presented in Table 1. In total, 209 
(76%) participants (116 women) who had undergone prophylactic colorectal surgery, representing 
111 of 135 Swedish families with FAP, were enrolled in the study (Table 1). No statistically 
significant differences in demographic and clinical characteristics were found between the 
participants and nonparticipants or between participating men and women (data not shown). The 
removal of the colon or colo:rectum had been performed in all but three participants who had 
undergone segmental resection of the colon. Sixty:three percent of the participants had undergone 
one colorectal procedure, 32% two colorectal procedures, and 5% three or more colorectal 
procedures. At the time of the study, 34% had undergone an IRA, 39% an IPAA, 19% an ileostomy, 
and 7% a continent ileostomy. Furthermore, FAP:related cancer had been diagnosed in 24% of the 
participants. 
Table 1 about here 

 
Illness perceptions 
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The means and SDs of the IPQ:R components, and their inter:relationships are presented in Table 
2. Overall, patients perceived FAP to be chronic and that they had a coherent understanding of 
their condition. A stronger illness identity related to a perception of a more chronic timeline (r = 
0.301, p < 0.001) and a greater understanding of FAP was associated with having family 
members with FAP (r =0.264, p < 0.001), more stable disease (r = :0.203, p = 0.003) and less 
serious consequences (r = :0.343, p < 0.001). Lower mean value was found for the component 
timeline cyclical (lower scores indicate that the condition is not believed to be cyclical in nature). 
Cyclical timeline was lowest in men (r = :0.168, p =0.015) and those with higher educational 
attainment (r = 0.159, p =0.021), and strongly associated with greater illness identity (r = 0.560, p 
< 0.001) There was also a fairly low perception of personal control and this was associated with 
being more highly educated (r = 0.179, p =0.009) and perceiving FAP to have a shorter duration 
(r= :0.232, p < 0.001).  Overall, patients did not agree or disagree that FAP was a serious 
condition, but they were less likely to see it as serious if they were male (r = :0.231, p < 0.001), 
or had a family member with FAP (r = :0.281, p < 0.001) and more likely to perceive FAP as 
with serious consequences if they identified more symptoms as FAP related (r =0.553, p < 
0.001), thought it was a chronic (r =0.283, p < 0.001) and cyclical condition (r =0.326, p < 
0.001). On average patients did not agree that FAP was controlled by their treatment. Older age (r 
= :0.235, p < 0.001), the longer they had been diagnosed with FAP (r = :0.258, p < 0.001) and 
lower sense of personal control was associated with having poorer treatment control. Emotional 
responses to FAP were higher in women (r = :0.215, p < 0.02), those that perceived it as chronic 
(r =0.190, p < 0.06), less stable (r =0.325, p < 0.001), associated with more symptoms (r =0.430, 
p < 0.001) and especially if FAP had more serious consequences (r =0.621, p < 0.001). For the 
component causes, 92% of the patients believed that “heredity” was the reason for their disease. 
This explains the relatively low levels of psychological, immunity, risk factor and chance causal 
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attributions. Patients agreeing with these aforementioned causal attributions had poorer 
understanding of their FAP and were less likely to have the experience of having a family 
member with FAP. They also exhibited more serious consequences, emotional responses and 
unstable disease, moreover they were more likely to view FAP as a more acute condition (all 
other relationships were not significant at p<0.05, see table 2).  
   
Table 2 about here 


	

$	
	
In Table 3 are the results of the logistic regression. Although older age approached significance in 
the first step, socio:demographic factors were not able to explain adherence to surveillance (Χ
2
 = 
8.33, p = 0.80). Genetic factors were also non:significant (Χ
2
 = 9.77, p = 0.135). Although by step 3, 
a positive diagnosis for malignancy and a greater duration of time since diagnosis and last surgery 
were showing collectively a greater tendency to attend recommended surveillance (Χ
2
 = 31.58, p = 
0.05, Nagelkerke R
2
 = 0.258, 86.5% were classified correctly). However, after controlling for all 
these factors perceptions that FAP is a serious condition (Exp(β) =2.226, p=0.039, 95% CI 1.040: 
4.762) and those with more emotional distress (Exp(β) :0.424, p = 0.024, 95% CI 0.202: 0.893) 
about FAP were significantly more adherent to surveillance. Quality of life was not associated with 
adherence (Χ
2
 = 0.398, p = 0.310, Nagelkerke R
2
 = 0.381, 86.5% correctly classified), although 
quality of life was marginally lower in those who were attending endoscopic surveillance.  

%	
Factors associated with poorer physical quality of life were older age (β = :0.273, p< 0.001), and 
testing positive for the APC or MYH on a genetic test (β = :0.154, p< 0.001). Receiving specialist 
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care, duration of FAP, recovery time from last surgery and malignancy were not associated with 
physical health status, when controlling for socio:demographic and genetic factors. Illness 
perceptions however, significantly improved the model (R
2
=0.398, R
2
 change = 0.310, F=8.719, 
p<0.001), specifically having a greater number of FAP symptoms identified as being part of their 
FAP (β = :0.335, p< 0.001), more serious consequences (β =  :0.375, p< 0.001) and poorer treatment 
control (β =: 0.145, p< 0.028) were most associated with reduced physical health status (R
2
=0.398, 
R
2
 change = 0.310, F=8.719, p<0.001).  

Poorer mental wellbeing was associated with younger age (β = 0.253, p< 0.001), not having a family 
member with FAP (β = 0.204, p< 0.03), Clinical factors were not associated. However, illness 
perceptions were also associated with patients’ wellbeing (R
2
=0.319, R
2
 change = 0.271, F=6.723, 
p<0.001). Poorer mental wellbeing was associated with more symptoms associated with FAP (β = :
0.315, p< 0.001), more serious consequences (β = :0.180, p< 0.049), emotion associated with FAP 
(β = :0.169, p< 0.035), thinking of FAP as more of an acute problem (β = 163, p< 0.026) and 
attributing the cause of FAP to psychological factors rather than genetic (β = :0.218, p< 0.033).  
 
&	



'

The prevalence of non –adherence to endoscopic surveillance was 14% in 76% of the Swedish 
population who have previously undergone prophylactic surgery. It is a very important issue as non:
adherent patients have a substantially increased risk of developing future malignancies.  The results 
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suggest that cancer prevention from an adherence to surveillance perspective is related to patients’ 
beliefs about their FAP. It is possible that those who perceive FAP to be less serious and less 
emotional were at greater risk of not attending surveillance. Those who held beliefs that FAP was 
less serious and emotional were male and who had a family member with FAP, this could be due to 
lower symptom perception in men, or increased complacency due to increased exposure to FAP. 
Alternatively, it is possible that that those who had recently undergone endoscopic surveillance (i.e. 
those adherent) suffered with greater distress associated with FAP and been more recently reminded 
about the seriousness of FAP. Those who avoided the surveillance may have more positive 
perceptions and avoided an unpleasant endoscopic procedure in the short term, but with the cost of 
being at greater risk of future morbidity and mortality (Vasen 2008). A tentative explanation of the 
result could be that non:adherent patients lack knowledge about the risk of the disease’s progress 
and that the treatment guidelines recommend surveillance throughout life in patients with FAP.
12. 
  
 
HRQoL was not associated with attendance at surveillance, instead emotion specific to FAP was 
associated with adherence. However, there were individual differences in living with FAP and those 
participants at greater risk have different socio:demographic backgrounds, genetic risk factors, and 
clinical histories, but out of all these factors, illness perceptions were able to explain unique variance 
in patient physical and mental quality of life.  
 
Previous research has also indicated that non:adherence to surveillance is a significant problem in 
patient with FAP [6]. Kinney and colleagues found that 46% of their participants were non:
adherence to recommended surveillance protocols. Their higher rates of non:adherence compared to 
the present study may partly be due to lack of health insurance for CRC surveillance in the US. 
However, consistently with the Swedish sample, patients’ beliefs about the condition were important 
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in their decisions about whether to attend surveillance or not.  Whereas previous studies have found 
that non: adherence to surveillance is associated with patients who believe there is no increase in 
relative risk associated with developing cancer [6] and beliefs that the treatment will not be effective 
at curing or controlling the condition [19], the present study found that FAP distress and 
consequences of FAP were worse in those who attend surveillance.  One explanation is that during 
the course of lifelong surveillance patients get more complacent. The longer they have lived with the 
condition without malignancy and the longer they have lived with FAP without further surgical 
interventions, their percepti n of the seriousness of FAP and living with FAP becomes less 
distressing over time. This more positive perception may have been created out of a false sense of 
security over a number of years without malignancy or surgical intervention and then an absence of 
perceived risk results in patients not attending surveillance. Alternatively, it is possible that 
attending surveillance causes patients to become more distressed and to view FAP as a more serious 
condition. However, given the frequency of surveillance and the relationships that negative illness 
perceptions have with HRQoL it is possible that surveillance induced distress may lead to reduced 
HRQoL indirectly via negative illness perceptions.  
 
Consistently with the Self:Regulation Model, the findings indicated that negative illness perceptions 
were related to reduced HRQoL [10], in particular stronger illness identity, more serious 
consequences, and poorer treatment control were directly associated with poorer HRQoL.  In 
addition, greater FAP distress, thinking about FAP as an acute problem instead of a chronic lifelong 
condition, and attributing the cause of FAP to psychological factors rather than genetic was 
associated with poorer mental HRQoL. This suggest that participants endorsing unrealistic 
perceptions of the duration and cause of FAP might be at greater risk of poorer psychological 
wellbeing.  The present study adds to a body of research indicating that illness perceptions are an 
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important consideration in precancerous and increased risk populations [18], and in particular with 
FAP, because of the continued lifelong surveillance, these findings point to the importance of 
realistic and healthy beliefs for improved adherence and HRQoL with repeated surveillance.   
 
The advantage to identifying modifiable beliefs associated with adherence, is that they may have 
clinical implication. Beliefs about FAP are amendable to change in a cognitive behavioral 
intervention, in order to increase uptake of endoscopic surveillance, or improve quality of life. A 
previous study showed that including illness perception assessments in communication with patients 
during outpatient visits has a positive effect on their involvement in discussions about treatment and 
care.
24
 In addition, providing disease:specific information has been reported to be associated with 
greater personal and treatment control and a better understanding of the illness in cancer survivors.
25 
Therefore, interventions aiming to improve illness perceptions may also be beneficial for this group 
of patients, since FAP is a life:long illness, and a commitment to a lifelong endoscopic surveillance 
program after prophylactic surgery is necessary to prevent cancer. 
 
The study has several strengths. First, the patients were recruit d from a national cohort of patients 
with FAP, including all known FAP cases in Sweden who had undergone surgery. Second, the 
high response rate resulted in a large, representative sample allowing analysis at a multivariate 
level. Finally, we used standardised and robust self:report measures. A limitation of the study is 
the cross:sectional design, which precludes the assessment of causal relationships. However, given 
the significant findings future research should look at the causal pathways between genetic, clinical 
and psychological factors in relation to adherence to surveillance.  

(


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Despite the importance of endoscopic surveillance in reducing the risk of future malignancy in FAP, 
some patients are non:adherent. Patients may be at greater risk of non:adherence to endoscopic 
surveillance as they get older, if they have not yet developed a malignancy, and a longer time since 
they had prophylactic surgery. Despite the greater increased risk to these patients, they viewed FAP 
to be less emotionally distressing and have fewer grave consequences. Men were also more inclined 
to view FAP as less serious and emotional compared to women.  Having other family members with 
FAP seemed to increase the compliancy of the severity of FAP. Attending surveillance was not 
associated with significantly poorer quality of life, rather it was patients’ socio:demographic 
background, genetic risk and illness perceptions that were important in explaining differences in 
attendance. Unhelpful representations for mental wellbeing, were viewing FAP as a more acute and 
psychologically caused problem, instead of a chronic, genetic condition. These findings have 
implications for supporting patients living with FAP, so that they do not put themselves at 
unnecessary risk of malignancy while trying to support patients living with the condition.  

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Table 1: Clinical characteristics of the Participating Patients with FAP (N = 209) 
 mean (SD; range) n % 
Sex    
 Men    93 44 
 Women  116 56 
Age (years)    
 All 49 (14; 18-75)   
 Men 48 (15; 18-75)    
 Women 49 (13; 23-74)   
Living situation 
 Partnered  139 67 
 Single     61 29 
 Living with parents or other      9   4 
Education level 
 Elementary school    56 27 
 High school    79 38 
 University    70 34 
Family members with FAP
 
 169 81 
Tested Positive for APC/MYH  166 79 
Age at diagnosis (years) 26 (12; 3-57)   
Time since first colorectal surgery to study (years) 21 (12; 1-50)   
Times since last colorectal surgery to study (years) 14 (10; 1-50)   
Received a cancer diagnosis   50 24 
Specialist Care  57 27 
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Table 2: Perceptions of FAP and their association with socio-demographic, genetic and clinical factors.  
Identity Timeline 
Cyclical 
Timeline Consequences 
Personal 
Control 
Treatment 
Control 
Coherenc
e 
Emotion
al Reps 
Psychological 
attribution 
Risk factor 
attribution 
Immune 
attribution 
Chance 
attributio
n 
Mean  
(SD) 
6.49 
(4.16) 
4.51 
(0.60) 
2.55  
(1.00) 
2.79  
(0.94) 
2.75 
(0.73) 
3.00  
(0.77) 
4.01 
(0.85) 
2.62 
(0.96) 
1.47 (0.64) 
1.95  
(0.52) 
1.71  
(0.72) 
1.88  
(0.80) 
Age  -.115 -.083 -.073 -.022 -.014 -.235
**
 -.018 -.110 .097 .133 .069 -.037 
Male -.268
**
 -.053 -.168
*
 -.231
**
 -.006 -.019 -.052 -.215
**
 -.019 -.025 .027 .056 
Higher Education .163
*
 .129 .159
*
 .096 .179
**
 .083 .105 .091 -.075 -.039 -.019 .036 
FAP in Family .064 .103 -.025 -.218
**
 -.015 -.008 .264
**
 -.128 -.258
**
 -.068 -.286
**
 -.126 
Tested Positive for 
APC/MYH 
-.057 .103 -.025 -.218
**
 -.015 -.008 .264
**
 -.128 -.258
**
 -.068 -.286
**
 -.126 
Years since diagnosis .108 .035 -.090 -.094 .028 -.258
**
 .076 -.067 .016 .072 -.034 -.064 
Years since the last 
surgery 
-.070 .026 -.031 -.083 -.053 -.126 .002 -.026 .011 .038 -.044 -.094 
Cancer diagnosis  -.085 .112 .035 -.116 .014 .067 .032 -.008 -.071 -.006 -.075 .049 
Specialist Care .025 .040 .044 .014 .009 .056 .051 .042 -.038 -.002 .028 .004 
Identity    .301
**
 .560
**
 .553
**
 .057 -.067 -.109 .430
**
 .094 .112 .162
*
 .039 
Timeline     .074 .283
**
 -.232
**
 -.260
**
 .046 .190
**
 -.233
**
 -.167
*
 -.226
**
 -.168
*
 
Cyclical Timeline       .326
**
 .150
*
 .039 -.203
**
 .325
**
 .256
**
 .161
*
 .206
**
 .135 
Consequences         .000 -.115 -.343
**
 .621
**
 .249
**
 .174
*
 .283
**
 .171
*
 
Personal Control           .311
**
 .028 -.053 .190
**
 .149
*
 .167
*
 .056 
Treatment Control             .116 -.064 -.022 -.039 -.082 -.069 
Coherence               -.320
**
 -.357
**
 -.206
**
 -.233
**
 -.228
**
 
Emotional Reps                 .184
**
 .119 .142
*
 .030 
Psychological 
attribution 
                  .721
**
 .671
**
 .365
**
 
Risk factor attribution                     .628
**
 .346
**
 
Immune attribution                       .386
**
 
Accident/chance 
attribution 
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Table 3: Factors associated with non-adherence to recommended surveillance  
Step Wald Sig Exp(B) 95% CI 
Adherent  
(N = 180) 
Mean/N* 
Not Adherent 
(N =  29) 
Mean/N* 
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*In parenthesis are the frequencies expected by chance. Specialist care was dropped from the model 
because all were adherent.  
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Table 4: Factors associated with quality of life in survivors of FAP  
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-chg= change,    β standardised regression coefficient  
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